Exogenous rLGALS9 triggers the death of colorectal cancer cells with refractory KRAS gene mutations by mediating clathrin- and PRKC (protein kinase C)-, RAF1-, and MAP2K1-. This evidence concerns the gene MAP2K1 and colorectal cancer.